A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners

Abstract Glycans play a pivotal role in biology. However, because of the low-affinity of glycan-protein interactions, many interaction pairs remain unknown. Two important glycoproteins involved in B-cell biology are the B-cell receptor and its secreted counterpart, antibodies. It has been indicated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Glycobiology (Oxford) 2023-10, Vol.33 (9), p.732-744
Hauptverfasser: Holborough-Kerkvliet, Miles D, Mucignato, Greta, Moons, Sam J, Psomiadou, Venetia, Konada, Rohit S R, Pedowitz, Nichole J, Pratt, Matthew R, Kissel, Theresa, Koeleman, Carolien A M, Tjokrodirijo, Rayman T N, van Veelen, Petrus A, Huizinga, Thomas, van Schie, Karin A J, Wuhrer, Manfred, Kohler, Jennifer J, Bonger, Kimberly M, Boltje, Thomas J, Toes, Reinaldus E M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 744
container_issue 9
container_start_page 732
container_title Glycobiology (Oxford)
container_volume 33
creator Holborough-Kerkvliet, Miles D
Mucignato, Greta
Moons, Sam J
Psomiadou, Venetia
Konada, Rohit S R
Pedowitz, Nichole J
Pratt, Matthew R
Kissel, Theresa
Koeleman, Carolien A M
Tjokrodirijo, Rayman T N
van Veelen, Petrus A
Huizinga, Thomas
van Schie, Karin A J
Wuhrer, Manfred
Kohler, Jennifer J
Bonger, Kimberly M
Boltje, Thomas J
Toes, Reinaldus E M
description Abstract Glycans play a pivotal role in biology. However, because of the low-affinity of glycan-protein interactions, many interaction pairs remain unknown. Two important glycoproteins involved in B-cell biology are the B-cell receptor and its secreted counterpart, antibodies. It has been indicated that glycans expressed by these B-cell-specific molecules can modulate immune activation via glycan-binding proteins. In several autoimmune diseases, an increased prevalence of variable domain glycosylation of IgG autoantibodies has been observed. Especially, the hallmarking autoantibodies in rheumatoid arthritis, anti-citrullinated protein antibodies, carry a substantial amount of variable domain glycans. The variable domain glycans expressed by these autoantibodies are N-linked, complex-type, and α2–6 sialylated, and B-cell receptors carrying variable domain glycans have been hypothesized to promote selection of autoreactive B cells via interactions with glycan-binding proteins. Here, we use the anti-citrullinated protein antibody response as a prototype to study potential in solution and in situ B-cell receptor–variable domain glycan interactors. We employed SiaDAz, a UV-activatable sialic acid analog carrying a diazirine moiety that can form covalent bonds with proximal glycan-binding proteins. We show, using oligosaccharide engineering, that SiaDAz can be readily incorporated into variable domain glycans of both antibodies and B-cell receptors. Our data show that antibody variable domain glycans are able to interact with inhibitory receptor, CD22. Interestingly, although we did not detect this interaction on the cell surface, we captured CD79 β glycan–B-cell receptor interactions. These results show the utility of combining photoaffinity labeling and oligosaccharide engineering for identifying antibody and B-cell receptor interactions and indicate that variable domain glycans appear not to be lectin cis ligands in our tested conditions.
doi_str_mv 10.1093/glycob/cwad055
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10627247</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/glycob/cwad055</oup_id><sourcerecordid>2843034368</sourcerecordid><originalsourceid>FETCH-LOGICAL-c425t-7f4d50e3baa51efa984c7bda38029b0fde3ed38b571fefee8dc369555899fd693</originalsourceid><addsrcrecordid>eNqFkU1v1DAURS0EoqWwZYmyhEVaO7YTZ4Wqii-pEhvYYj3bzxmjxA520mr-PRnNtCorVn6Szz3P1iXkLaOXjPb8ahj3Npkrew-OSvmMnDPR0roRDX_-ZD4jr0r5TSlrmZIvyRnvRK9Y152TX9fVvEtLAu9DDMu-Oggh1iMYHEMcKpjnnMDuqiVVId5hWcIAC1ZhmtaYhjGZdeMeYiZEd0jNkJeIubwmLzyMBd-czgvy8_OnHzdf69vvX77dXN_WVjRyqTsvnKTIDYBk6KFXwnbGAVe06Q31Djk6rozsmEePqJzlbS-lVH3vXdvzC_Lx6J1XM6GzGJcMo55zmCDvdYKg_72JYaeHdKcZbZuuEd1meH8y5PRn3b6pp1AsjiNETGvRjRKccsFbtaGXR9TmVEpG_7iHUX1oRR9b0adWtsC7p697xB9q2IAPRyCt8_9kfwF1lJ2g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2843034368</pqid></control><display><type>article</type><title>A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Holborough-Kerkvliet, Miles D ; Mucignato, Greta ; Moons, Sam J ; Psomiadou, Venetia ; Konada, Rohit S R ; Pedowitz, Nichole J ; Pratt, Matthew R ; Kissel, Theresa ; Koeleman, Carolien A M ; Tjokrodirijo, Rayman T N ; van Veelen, Petrus A ; Huizinga, Thomas ; van Schie, Karin A J ; Wuhrer, Manfred ; Kohler, Jennifer J ; Bonger, Kimberly M ; Boltje, Thomas J ; Toes, Reinaldus E M</creator><creatorcontrib>Holborough-Kerkvliet, Miles D ; Mucignato, Greta ; Moons, Sam J ; Psomiadou, Venetia ; Konada, Rohit S R ; Pedowitz, Nichole J ; Pratt, Matthew R ; Kissel, Theresa ; Koeleman, Carolien A M ; Tjokrodirijo, Rayman T N ; van Veelen, Petrus A ; Huizinga, Thomas ; van Schie, Karin A J ; Wuhrer, Manfred ; Kohler, Jennifer J ; Bonger, Kimberly M ; Boltje, Thomas J ; Toes, Reinaldus E M</creatorcontrib><description>Abstract Glycans play a pivotal role in biology. However, because of the low-affinity of glycan-protein interactions, many interaction pairs remain unknown. Two important glycoproteins involved in B-cell biology are the B-cell receptor and its secreted counterpart, antibodies. It has been indicated that glycans expressed by these B-cell-specific molecules can modulate immune activation via glycan-binding proteins. In several autoimmune diseases, an increased prevalence of variable domain glycosylation of IgG autoantibodies has been observed. Especially, the hallmarking autoantibodies in rheumatoid arthritis, anti-citrullinated protein antibodies, carry a substantial amount of variable domain glycans. The variable domain glycans expressed by these autoantibodies are N-linked, complex-type, and α2–6 sialylated, and B-cell receptors carrying variable domain glycans have been hypothesized to promote selection of autoreactive B cells via interactions with glycan-binding proteins. Here, we use the anti-citrullinated protein antibody response as a prototype to study potential in solution and in situ B-cell receptor–variable domain glycan interactors. We employed SiaDAz, a UV-activatable sialic acid analog carrying a diazirine moiety that can form covalent bonds with proximal glycan-binding proteins. We show, using oligosaccharide engineering, that SiaDAz can be readily incorporated into variable domain glycans of both antibodies and B-cell receptors. Our data show that antibody variable domain glycans are able to interact with inhibitory receptor, CD22. Interestingly, although we did not detect this interaction on the cell surface, we captured CD79 β glycan–B-cell receptor interactions. These results show the utility of combining photoaffinity labeling and oligosaccharide engineering for identifying antibody and B-cell receptor interactions and indicate that variable domain glycans appear not to be lectin cis ligands in our tested conditions.</description><identifier>ISSN: 1460-2423</identifier><identifier>ISSN: 0959-6658</identifier><identifier>EISSN: 1460-2423</identifier><identifier>DOI: 10.1093/glycob/cwad055</identifier><identifier>PMID: 37498177</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Original</subject><ispartof>Glycobiology (Oxford), 2023-10, Vol.33 (9), p.732-744</ispartof><rights>The Author(s) 2023. Published by Oxford University Press. 2023</rights><rights>The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c425t-7f4d50e3baa51efa984c7bda38029b0fde3ed38b571fefee8dc369555899fd693</citedby><cites>FETCH-LOGICAL-c425t-7f4d50e3baa51efa984c7bda38029b0fde3ed38b571fefee8dc369555899fd693</cites><orcidid>0000-0002-8835-2355 ; 0000-0001-9141-8784 ; 0000-0001-5373-3329</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37498177$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Holborough-Kerkvliet, Miles D</creatorcontrib><creatorcontrib>Mucignato, Greta</creatorcontrib><creatorcontrib>Moons, Sam J</creatorcontrib><creatorcontrib>Psomiadou, Venetia</creatorcontrib><creatorcontrib>Konada, Rohit S R</creatorcontrib><creatorcontrib>Pedowitz, Nichole J</creatorcontrib><creatorcontrib>Pratt, Matthew R</creatorcontrib><creatorcontrib>Kissel, Theresa</creatorcontrib><creatorcontrib>Koeleman, Carolien A M</creatorcontrib><creatorcontrib>Tjokrodirijo, Rayman T N</creatorcontrib><creatorcontrib>van Veelen, Petrus A</creatorcontrib><creatorcontrib>Huizinga, Thomas</creatorcontrib><creatorcontrib>van Schie, Karin A J</creatorcontrib><creatorcontrib>Wuhrer, Manfred</creatorcontrib><creatorcontrib>Kohler, Jennifer J</creatorcontrib><creatorcontrib>Bonger, Kimberly M</creatorcontrib><creatorcontrib>Boltje, Thomas J</creatorcontrib><creatorcontrib>Toes, Reinaldus E M</creatorcontrib><title>A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners</title><title>Glycobiology (Oxford)</title><addtitle>Glycobiology</addtitle><description>Abstract Glycans play a pivotal role in biology. However, because of the low-affinity of glycan-protein interactions, many interaction pairs remain unknown. Two important glycoproteins involved in B-cell biology are the B-cell receptor and its secreted counterpart, antibodies. It has been indicated that glycans expressed by these B-cell-specific molecules can modulate immune activation via glycan-binding proteins. In several autoimmune diseases, an increased prevalence of variable domain glycosylation of IgG autoantibodies has been observed. Especially, the hallmarking autoantibodies in rheumatoid arthritis, anti-citrullinated protein antibodies, carry a substantial amount of variable domain glycans. The variable domain glycans expressed by these autoantibodies are N-linked, complex-type, and α2–6 sialylated, and B-cell receptors carrying variable domain glycans have been hypothesized to promote selection of autoreactive B cells via interactions with glycan-binding proteins. Here, we use the anti-citrullinated protein antibody response as a prototype to study potential in solution and in situ B-cell receptor–variable domain glycan interactors. We employed SiaDAz, a UV-activatable sialic acid analog carrying a diazirine moiety that can form covalent bonds with proximal glycan-binding proteins. We show, using oligosaccharide engineering, that SiaDAz can be readily incorporated into variable domain glycans of both antibodies and B-cell receptors. Our data show that antibody variable domain glycans are able to interact with inhibitory receptor, CD22. Interestingly, although we did not detect this interaction on the cell surface, we captured CD79 β glycan–B-cell receptor interactions. These results show the utility of combining photoaffinity labeling and oligosaccharide engineering for identifying antibody and B-cell receptor interactions and indicate that variable domain glycans appear not to be lectin cis ligands in our tested conditions.</description><subject>Original</subject><issn>1460-2423</issn><issn>0959-6658</issn><issn>1460-2423</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNqFkU1v1DAURS0EoqWwZYmyhEVaO7YTZ4Wqii-pEhvYYj3bzxmjxA520mr-PRnNtCorVn6Szz3P1iXkLaOXjPb8ahj3Npkrew-OSvmMnDPR0roRDX_-ZD4jr0r5TSlrmZIvyRnvRK9Y152TX9fVvEtLAu9DDMu-Oggh1iMYHEMcKpjnnMDuqiVVId5hWcIAC1ZhmtaYhjGZdeMeYiZEd0jNkJeIubwmLzyMBd-czgvy8_OnHzdf69vvX77dXN_WVjRyqTsvnKTIDYBk6KFXwnbGAVe06Q31Djk6rozsmEePqJzlbS-lVH3vXdvzC_Lx6J1XM6GzGJcMo55zmCDvdYKg_72JYaeHdKcZbZuuEd1meH8y5PRn3b6pp1AsjiNETGvRjRKccsFbtaGXR9TmVEpG_7iHUX1oRR9b0adWtsC7p697xB9q2IAPRyCt8_9kfwF1lJ2g</recordid><startdate>20231029</startdate><enddate>20231029</enddate><creator>Holborough-Kerkvliet, Miles D</creator><creator>Mucignato, Greta</creator><creator>Moons, Sam J</creator><creator>Psomiadou, Venetia</creator><creator>Konada, Rohit S R</creator><creator>Pedowitz, Nichole J</creator><creator>Pratt, Matthew R</creator><creator>Kissel, Theresa</creator><creator>Koeleman, Carolien A M</creator><creator>Tjokrodirijo, Rayman T N</creator><creator>van Veelen, Petrus A</creator><creator>Huizinga, Thomas</creator><creator>van Schie, Karin A J</creator><creator>Wuhrer, Manfred</creator><creator>Kohler, Jennifer J</creator><creator>Bonger, Kimberly M</creator><creator>Boltje, Thomas J</creator><creator>Toes, Reinaldus E M</creator><general>Oxford University Press</general><scope>TOX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8835-2355</orcidid><orcidid>https://orcid.org/0000-0001-9141-8784</orcidid><orcidid>https://orcid.org/0000-0001-5373-3329</orcidid></search><sort><creationdate>20231029</creationdate><title>A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners</title><author>Holborough-Kerkvliet, Miles D ; Mucignato, Greta ; Moons, Sam J ; Psomiadou, Venetia ; Konada, Rohit S R ; Pedowitz, Nichole J ; Pratt, Matthew R ; Kissel, Theresa ; Koeleman, Carolien A M ; Tjokrodirijo, Rayman T N ; van Veelen, Petrus A ; Huizinga, Thomas ; van Schie, Karin A J ; Wuhrer, Manfred ; Kohler, Jennifer J ; Bonger, Kimberly M ; Boltje, Thomas J ; Toes, Reinaldus E M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c425t-7f4d50e3baa51efa984c7bda38029b0fde3ed38b571fefee8dc369555899fd693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Holborough-Kerkvliet, Miles D</creatorcontrib><creatorcontrib>Mucignato, Greta</creatorcontrib><creatorcontrib>Moons, Sam J</creatorcontrib><creatorcontrib>Psomiadou, Venetia</creatorcontrib><creatorcontrib>Konada, Rohit S R</creatorcontrib><creatorcontrib>Pedowitz, Nichole J</creatorcontrib><creatorcontrib>Pratt, Matthew R</creatorcontrib><creatorcontrib>Kissel, Theresa</creatorcontrib><creatorcontrib>Koeleman, Carolien A M</creatorcontrib><creatorcontrib>Tjokrodirijo, Rayman T N</creatorcontrib><creatorcontrib>van Veelen, Petrus A</creatorcontrib><creatorcontrib>Huizinga, Thomas</creatorcontrib><creatorcontrib>van Schie, Karin A J</creatorcontrib><creatorcontrib>Wuhrer, Manfred</creatorcontrib><creatorcontrib>Kohler, Jennifer J</creatorcontrib><creatorcontrib>Bonger, Kimberly M</creatorcontrib><creatorcontrib>Boltje, Thomas J</creatorcontrib><creatorcontrib>Toes, Reinaldus E M</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Glycobiology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Holborough-Kerkvliet, Miles D</au><au>Mucignato, Greta</au><au>Moons, Sam J</au><au>Psomiadou, Venetia</au><au>Konada, Rohit S R</au><au>Pedowitz, Nichole J</au><au>Pratt, Matthew R</au><au>Kissel, Theresa</au><au>Koeleman, Carolien A M</au><au>Tjokrodirijo, Rayman T N</au><au>van Veelen, Petrus A</au><au>Huizinga, Thomas</au><au>van Schie, Karin A J</au><au>Wuhrer, Manfred</au><au>Kohler, Jennifer J</au><au>Bonger, Kimberly M</au><au>Boltje, Thomas J</au><au>Toes, Reinaldus E M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners</atitle><jtitle>Glycobiology (Oxford)</jtitle><addtitle>Glycobiology</addtitle><date>2023-10-29</date><risdate>2023</risdate><volume>33</volume><issue>9</issue><spage>732</spage><epage>744</epage><pages>732-744</pages><issn>1460-2423</issn><issn>0959-6658</issn><eissn>1460-2423</eissn><abstract>Abstract Glycans play a pivotal role in biology. However, because of the low-affinity of glycan-protein interactions, many interaction pairs remain unknown. Two important glycoproteins involved in B-cell biology are the B-cell receptor and its secreted counterpart, antibodies. It has been indicated that glycans expressed by these B-cell-specific molecules can modulate immune activation via glycan-binding proteins. In several autoimmune diseases, an increased prevalence of variable domain glycosylation of IgG autoantibodies has been observed. Especially, the hallmarking autoantibodies in rheumatoid arthritis, anti-citrullinated protein antibodies, carry a substantial amount of variable domain glycans. The variable domain glycans expressed by these autoantibodies are N-linked, complex-type, and α2–6 sialylated, and B-cell receptors carrying variable domain glycans have been hypothesized to promote selection of autoreactive B cells via interactions with glycan-binding proteins. Here, we use the anti-citrullinated protein antibody response as a prototype to study potential in solution and in situ B-cell receptor–variable domain glycan interactors. We employed SiaDAz, a UV-activatable sialic acid analog carrying a diazirine moiety that can form covalent bonds with proximal glycan-binding proteins. We show, using oligosaccharide engineering, that SiaDAz can be readily incorporated into variable domain glycans of both antibodies and B-cell receptors. Our data show that antibody variable domain glycans are able to interact with inhibitory receptor, CD22. Interestingly, although we did not detect this interaction on the cell surface, we captured CD79 β glycan–B-cell receptor interactions. These results show the utility of combining photoaffinity labeling and oligosaccharide engineering for identifying antibody and B-cell receptor interactions and indicate that variable domain glycans appear not to be lectin cis ligands in our tested conditions.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>37498177</pmid><doi>10.1093/glycob/cwad055</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-8835-2355</orcidid><orcidid>https://orcid.org/0000-0001-9141-8784</orcidid><orcidid>https://orcid.org/0000-0001-5373-3329</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1460-2423
ispartof Glycobiology (Oxford), 2023-10, Vol.33 (9), p.732-744
issn 1460-2423
0959-6658
1460-2423
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10627247
source Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Original
title A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T22%3A18%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20photoaffinity%20glycan-labeling%20approach%20to%20investigate%20immunoglobulin%20glycan-binding%20partners&rft.jtitle=Glycobiology%20(Oxford)&rft.au=Holborough-Kerkvliet,%20Miles%20D&rft.date=2023-10-29&rft.volume=33&rft.issue=9&rft.spage=732&rft.epage=744&rft.pages=732-744&rft.issn=1460-2423&rft.eissn=1460-2423&rft_id=info:doi/10.1093/glycob/cwad055&rft_dat=%3Cproquest_pubme%3E2843034368%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2843034368&rft_id=info:pmid/37498177&rft_oup_id=10.1093/glycob/cwad055&rfr_iscdi=true